Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
FAQ Preliminary Phase 2 data shows Retatrutide achieved -24.2% weight loss in 48 weeks, while Mounjaro in Phase 3 showed -22.5% in 72 weeks
After a review of the totality of information, including all clinical data generated to date for danuglipron and recent input from regulators, Pfizer decided to discontinue development of the molecule
Are there any downsides to GLP therapies
Upon receipt, products should be stored away from heat and light
Comparisons with previous in vivo studies with praziquantel suggests that these inhibitors outperform the drug of choice for schistosomiasis against juvenile worms
LY3437943, a novel triple GIP, GLP-1 and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multi-escalating-amount trial
